These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 11290327)

  • 1. Structural mechanism for rifampicin inhibition of bacterial rna polymerase.
    Campbell EA; Korzheva N; Mustaev A; Murakami K; Nair S; Goldfarb A; Darst SA
    Cell; 2001 Mar; 104(6):901-12. PubMed ID: 11290327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of RNA Polymerase by Rifampicin and Rifamycin-Like Molecules.
    Mosaei H; Zenkin N
    EcoSal Plus; 2020 Apr; 9(1):. PubMed ID: 32342856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription inhibition by the depsipeptide antibiotic salinamide A.
    Degen D; Feng Y; Zhang Y; Ebright KY; Ebright YW; Gigliotti M; Vahedian-Movahed H; Mandal S; Talaue M; Connell N; Arnold E; Fenical W; Ebright RH
    Elife; 2014 Apr; 3():e02451. PubMed ID: 24843001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription inactivation through local refolding of the RNA polymerase structure.
    Belogurov GA; Vassylyeva MN; Sevostyanova A; Appleman JR; Xiang AX; Lira R; Webber SE; Klyuyev S; Nudler E; Artsimovitch I; Vassylyev DG
    Nature; 2009 Jan; 457(7227):332-5. PubMed ID: 18946472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3).
    Lin W; Das K; Degen D; Mazumder A; Duchi D; Wang D; Ebright YW; Ebright RY; Sineva E; Gigliotti M; Srivastava A; Mandal S; Jiang Y; Liu Y; Yin R; Zhang Z; Eng ET; Thomas D; Donadio S; Zhang H; Zhang C; Kapanidis AN; Ebright RH
    Mol Cell; 2018 Apr; 70(1):60-71.e15. PubMed ID: 29606590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donation of catalytic residues to RNA polymerase active center by transcription factor Gre.
    Sosunova E; Sosunov V; Kozlov M; Nikiforov V; Goldfarb A; Mustaev A
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15469-74. PubMed ID: 14668436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallization and preliminary X-ray crystallographic analyses of Thermus thermophilus backtracked RNA polymerase.
    Murayama Y; Sekine S; Yokoyama S
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Feb; 69(Pt 2):174-7. PubMed ID: 23385762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of bacterial RNA polymerase by streptolydigin: stabilization of a straight-bridge-helix active-center conformation.
    Tuske S; Sarafianos SG; Wang X; Hudson B; Sineva E; Mukhopadhyay J; Birktoft JJ; Leroy O; Ismail S; Clark AD; Dharia C; Napoli A; Laptenko O; Lee J; Borukhov S; Ebright RH; Arnold E
    Cell; 2005 Aug; 122(4):541-52. PubMed ID: 16122422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the Escherichia coli RNA polymerase alpha subunit C-terminal domain.
    Lara-González S; Birktoft JJ; Lawson CL
    Acta Crystallogr D Biol Crystallogr; 2010 Jul; 66(Pt 7):806-12. PubMed ID: 20606261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RNA polymerase "switch region" is a target for inhibitors.
    Mukhopadhyay J; Das K; Ismail S; Koppstein D; Jang M; Hudson B; Sarafianos S; Tuske S; Patel J; Jansen R; Irschik H; Arnold E; Ebright RH
    Cell; 2008 Oct; 135(2):295-307. PubMed ID: 18957204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA polymerase III α subunit from Mycobacterium tuberculosis H37Rv: Homology modeling and molecular docking of its inhibitor.
    Chhabra G; Dixit A; C Garg L
    Bioinformation; 2011 Mar; 6(2):69-73. PubMed ID: 21544168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampin: mechanisms of action and resistance.
    Wehrli W
    Rev Infect Dis; 1983; 5 Suppl 3():S407-11. PubMed ID: 6356275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to rifampicin: a review.
    Goldstein BP
    J Antibiot (Tokyo); 2014 Sep; 67(9):625-30. PubMed ID: 25118103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifamycin-mode of action, resistance, and biosynthesis.
    Floss HG; Yu TW
    Chem Rev; 2005 Feb; 105(2):621-32. PubMed ID: 15700959
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of rifamycin on protein synthesis.
    Calvori C; Frontali L; Leoni L; Tecce G
    Nature; 1965 Jul; 207(995):417-8. PubMed ID: 4957347
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis.
    Taniguchi H; Aramaki H; Nikaido Y; Mizuguchi Y; Nakamura M; Koga T; Yoshida S
    FEMS Microbiol Lett; 1996 Oct; 144(1):103-8. PubMed ID: 8870258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.
    Jin DJ; Gross CA
    J Mol Biol; 1988 Jul; 202(1):45-58. PubMed ID: 3050121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the mechanism of rifampicin inhibition of RNA synthesis.
    McClure WR; Cech CL
    J Biol Chem; 1978 Dec; 253(24):8949-56. PubMed ID: 363713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specific inhibition of the DNA-directed RNA synthesis by rifamycin.
    Hartmann G; Honikel KO; Knüsel F; Nüesch J
    Biochim Biophys Acta; 1967; 145(3):843-4. PubMed ID: 4863911
    [No Abstract]   [Full Text] [Related]  

  • 20. The mechanism of action of penicillin. Penicillin acylates the active site of Bacillus stearothermophilus D-alanine carboxypeptidase.
    Yocum RR; Rasmussen JR; Strominger JL
    J Biol Chem; 1980 May; 255(9):3977-86. PubMed ID: 7372662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.